Market Closed -
Other stock markets
|
After market 01:04:18 pm | |||
196 EUR | +1.01% | 195.8 | -0.05% |
May. 16 | Sartorius sinks again towards year low | DP |
May. 16 | Transcript : Sartorius Stedim Biotech S.A., Sartorius Aktiengesellschaft - Analyst/Investor Day |
Sales 2024 * | 2.94B 3.18B | Sales 2025 * | 3.33B 3.61B | Capitalization | 18.88B 20.46B |
---|---|---|---|---|---|
Net income 2024 * | 335M 363M | Net income 2025 * | 451M 489M | EV / Sales 2024 * | 7.2 x |
Net Debt 2024 * | 2.27B 2.46B | Net Debt 2025 * | 2.16B 2.34B | EV / Sales 2025 * | 6.32 x |
P/E ratio 2024 * |
54.6
x | P/E ratio 2025 * |
39.2
x | Employees | 10,493 |
Yield 2024 * |
0.38% | Yield 2025 * |
0.56% | Free-Float | 31.97% |
Latest transcript on Sartorius Stedim Biotech
1 day | +0.31% | ||
1 week | -9.49% | ||
Current month | -4.14% | ||
1 month | -0.97% | ||
3 months | -23.30% | ||
6 months | -3.90% | ||
Current year | -18.75% |
Managers | Title | Age | Since |
---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 48 | 19-03-25 |
Chairman | 59 | 07-06-28 | |
Chief Tech/Sci/R&D Officer | 59 | 09-04-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Henri Riey
BRD | Director/Board Member | 62 | 07-06-28 |
Chairman | 59 | 07-06-28 | |
Susan Dexter
BRD | Director/Board Member | 67 | 15-04-06 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.42% | 17 M€ | +8.99% | - | |
0.35% | 5 M€ | +4.56% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-22 | 196 | +1.01% | 79 016 |
24-05-21 | 194 | -0.84% | 86,459 |
24-05-20 | 195.6 | -0.58% | 73,262 |
24-05-17 | 196.8 | -4.33% | 119,591 |
24-05-16 | 205.7 | -4.33% | 175,718 |
Real-time Euronext Paris, May 22, 2024 at 10:53 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.75% | 20.5B | |
-5.49% | 179B | |
+3.95% | 113B | |
-3.59% | 67.88B | |
+5.57% | 52.03B | |
+5.58% | 43.3B | |
+4.03% | 41.79B | |
+25.03% | 32.49B | |
+14.00% | 25.65B | |
-4.37% | 24.55B |
- Stock Market
- Equities
- DIM Stock